BMO Global Health Care Fund (NEO:BGHC)
Canada
· Delayed Price · Currency is CAD 18.39
0.00 (0.00%)
Feb 21, 2025, 4:00 PM EST
18.57% (1Y)
| Assets | 131.71M |
| Expense Ratio | n/a |
| PE Ratio | n/a |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +18.57% |
| Volume | n/a |
| Open | 18.39 |
| Previous Close | 18.39 |
| Day's Range | 18.39 - 18.39 |
| 52-Week Low | 15.51 |
| 52-Week High | 19.53 |
| Beta | n/a |
| Holdings | 38 |
| Inception Date | Jun 26, 2023 |
About BGHC
BMO Global Health Care Fund is an exchange traded fund launched by BMO Investments Inc. The fund is managed by BMO Asset Management Inc. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies operating across health care sectors. It invests in value stocks of companies across diversified market capitalizations. The fund employs fundamental analysis to create its portfolio. BMO Global Health Care Fund was formed on June 26, 2023 and is domiciled in Canada.
Asset Class Equity
Category Health Care
Stock Exchange Cboe Canada
Ticker Symbol BGHC
Provider BMO
Performance
BGHC had a total return of 18.57% in the past year. Since the fund's inception, the average annual return has been 13.18%, including dividends.
Top 10 Holdings
56.58% of assets| Name | Symbol | Weight |
|---|---|---|
| UnitedHealth Group Incorporated | UNH | 10.13% |
| Eli Lilly and Company | LLY | 9.87% |
| AstraZeneca PLC | AZN | 5.66% |
| UCB SA | UCB | 5.09% |
| AbbVie Inc. | ABBV | 5.02% |
| Intuitive Surgical, Inc. | ISRG | 4.92% |
| Boston Scientific Corporation | BSX | 4.68% |
| Thermo Fisher Scientific Inc. | TMO | 4.07% |
| Abbott Laboratories | ABT | 3.88% |
| Johnson & Johnson | JNJ | 3.25% |